These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. Suryani S; Sutton I J Neuroimmunol; 2007 Feb; 183(1-2):96-103. PubMed ID: 17240458 [TBL] [Abstract][Full Text] [Related]
11. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis. Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156 [TBL] [Abstract][Full Text] [Related]
12. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ. Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120 [TBL] [Abstract][Full Text] [Related]
13. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251 [TBL] [Abstract][Full Text] [Related]
14. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase. Emerson MR; LeVine SM Brain Res; 2004 Sep; 1021(1):140-5. PubMed ID: 15328042 [TBL] [Abstract][Full Text] [Related]
15. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Xiao BG; Ma CG; Xu LY; Link H; Lu CZ Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713 [TBL] [Abstract][Full Text] [Related]
17. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation. Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144 [TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis. Parvaneh Tafreshi A Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570 [TBL] [Abstract][Full Text] [Related]
20. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Liu R; Bai Y; Vollmer TL; Bai XF; Jee Y; Tang YY; Campagnolo DI; Collins M; Young DA; La Cava A; Shi FD Exp Neurol; 2008 May; 211(1):14-24. PubMed ID: 18353312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]